Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,877 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Signal-finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.
Agarwal N, Castellano D, Alonso-Gordoa T, Arranz Arija JA, Colomba E, Gravis G, Mourey L, Oudard S, Fléchon A, Gonzalez M, Maroto PM, Schweizer MT, Gallardo E, Johnston E, Balar A, Haddad N, Appiah AK, Nacerddine K, Piulats JM. Agarwal N, et al. Among authors: gonzalez m. Clin Cancer Res. 2024 Mar 21. doi: 10.1158/1078-0432.CCR-23-3436. Online ahead of print. Clin Cancer Res. 2024. PMID: 38512117
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.
Garcia-Ruiz A, Macarro C, Zacchi F, Morales-Barrera R, Grussu F, Casanova-Salas I, Sanguedolce F, Gonzalez M, Cresta-Morgado P, de Albert M, Garcia-Bennett J, Marmolejo D, Planas J, Roche S, Mast R, Zatse C, Piulats JM, Herrera-Imbroda B, Regis L, Agundez L, Olmos D, Calvo N, Escobar M, Carles J, Mateo J, Perez-Lopez R. Garcia-Ruiz A, et al. Among authors: gonzalez m. Eur Urol. 2024 Mar 14:S0302-2838(24)02133-X. doi: 10.1016/j.eururo.2024.02.016. Online ahead of print. Eur Urol. 2024. PMID: 38490857 No abstract available.
Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment.
Morales-Barrera R, Villacampa G, Vidal N, Figols M, Giner J, Bonfill T, Suárez C, Díaz N, Mateo J, González M, Domenech M, Puente J, Carles J. Morales-Barrera R, et al. Among authors: gonzalez m. Clin Transl Oncol. 2023 Dec;25(12):3556-3564. doi: 10.1007/s12094-023-03213-6. Epub 2023 May 22. Clin Transl Oncol. 2023. PMID: 37217634
Nanoparticles as theranostic vehicles in prostate cancer.
Morales-Barrera R, Suárez C, Mateo J, González M, Carles J. Morales-Barrera R, et al. Among authors: gonzalez m. Ann Transl Med. 2019 Mar;7(Suppl 1):S29. doi: 10.21037/atm.2019.01.77. Ann Transl Med. 2019. PMID: 31032309 Free PMC article. No abstract available.
Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer.
Athie A, Arce-Gallego S, Gonzalez M, Morales-Barrera R, Suarez C, Casals Galobart T, Hernandez Viedma G, Carles J, Mateo J. Athie A, et al. Among authors: gonzalez m. Curr Oncol Rep. 2019 Mar 27;21(5):42. doi: 10.1007/s11912-019-0790-6. Curr Oncol Rep. 2019. PMID: 30919167 Review.
7,877 results